A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers.

Winrevair (sotatercept), a treatment for pulmonary arterial hypertension (PAH), has emerged as a promising candidate with the potential to reshape the PAH treatment landscape. Analysts are eagerly ...

Recent developments in Merck's pipeline have drawn considerable attention from investors and analysts. Winrevair (sotatercept), a treatment for pulmonary arterial hypertension (PAH), has emerged as a ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...

Titled “Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in ... which uses sound waves to visualize structures inside the body. 18F-FAPI PET is a new approach that ...

Nikola (NASDAQ:NKLA) was down 29% in afternoon trading on Thursday and swapped hands as low as $0.76 amid bankruptcy speculation. Electrek's Fred Lambert wrote on social media site X that a source ...